Karen Kozleski
Family · Medford, ORNPI 1043497126
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 18.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $908 and has fallen 97.5% since, to $23 in 2023.
Across 82 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$260
- GSK$157
- Amgen$145
- Biohaven Pharmaceuticals, Inc.$122
- Takeda Pharmaceuticals U.S.A., Inc.$110
- Lilly USA, LLC$93
- plus $554 from 13 others
What the payments were for
- Food & beverage$1,441100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 17 | $260 |
| GSK | 8 | $157 |
| Amgen | 8 | $145 |
| Biohaven Pharmaceuticals, Inc. | 8 | $122 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Lilly USA, LLC | 5 | $93 |
| AstraZeneca | 6 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $74 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $60 |
| AbbVie | 3 | $56 |
| Novo Nordisk | 3 | $53 |
| Bayer | 2 | $46 |
| Amarin Pharma, Inc. | 2 | $38 |
| Pfizer | 2 | $36 |
| Dexcom, Inc. | 2 | $32 |
| Ultragenyx Pharmaceutical Inc. | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $19 |
| Novartis | 1 | $19 |
| Astellas Pharma US Inc | 1 | $14 |
How this compares
$1,441 in reported general payments places this provider in the 85th percentile of 1,130 family providers in Oregon.
Other family in Medford
- David ArnopoleMedford$38K
- Denise PartinMedford$7K
- Sarah RobersonMedford$4K
- Jody HaasMedford$3K
- Molly ThompsonMedford$3K
- Heather BascomMedford$3K
- Rachel PangilinanPortland$103K
- Jodeanna SweeneyCentral Point$45K
- Lani DoserPortland$45K
- Heather HermanCorvallis$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.